Basourakos Spyridon P, Alshak Mark N, Lewicki Patrick J, Cheng Emily, Tzeng Michael, DeRosa Antonio P, Allaway Mathew J, Ross Ashley E, Schaeffer Edward M, Patel Hiten D, Hu Jim C, Gorin Michael A
Department of Urology, New York Presbyterian Hospital/Weil Cornell Medicine, New York, NY, USA.
Samuel J. Wood Library & C.V. Starr Biomedical Information Center, Weill Cornell Medicine, New York, NY, USA.
Eur Urol Open Sci. 2022 Jan 29;37:53-63. doi: 10.1016/j.euros.2022.01.001. eCollection 2022 Mar.
Transperineal prostate biopsy is associated with a significantly lower risk of infectious complications than the transrectal approach. In fact, the risk of infectious complications with transperineal prostate biopsy is so low that the utility of administering periprocedural antibiotics with this procedure has come under question.
To perform a systematic review and meta-analysis to assess for differences in the rates of infectious complications (septic, nonseptic, and overall) after performing transperineal prostate biopsy with and without the administration of periprocedural antibiotic prophylaxis.
Three electronic databases (PubMed, Embase, and MEDLINE) were searched, and studies were included if they included patients who underwent transperineal prostate biopsy, were published after January 2000, included information on periprocedural antibiotic administration, and reported postbiopsy complications. Preferred Reporting Items for Systematic Reviews and Meta-analyses and Agency for Healthcare Research and Quality guidelines were utilized.
A total of 106 unique studies describing 112 cohorts of patients were identified, of which 98 (37 805 men) received antibiotic prophylaxis and 14 (4772 men) did not receive it. All patients were included in the analysis of septic complications. In total, there were 19/37 805 (0.05%) episodes of sepsis in the group of men who received antibiotics, which was similar to the no antibiotic group with 4/4772 (0.08%) episodes ( = 0.2). For overall infections (septic plus nonseptic), there were 403/29 880 (1.35%) versus 58/4772 (1.22%) events among men with evaluable data who received and did not receive antibiotic prophylaxis, respectively ( = 0.8). Restricting our analysis to studies with a comparable low number of biopsy cores (<25 cores), there remained no difference in the rates of sepsis between groups, but there was a small, statistically significant lower risk of infectious complications with antibiotic administration-67/12 140 (0.55%) versus 58/4772 (1.22%; < 0.01).
The likelihood of septic infections after transperineal prostate biopsy is low with and without antibiotic prophylaxis. The omission of periprocedural antibiotics with this procedure stands to benefit patients by avoiding potential drug reactions. Furthermore, this practice is in line with calls throughout the medical community for improved antibiotic stewardship.
In a large systematic review and meta-analysis, we evaluated infectious complications after transperineal prostate biopsy with or without the administration of prophylactic antibiotics. We conclude that prophylactic antibiotics do not decrease the rate of postbiopsy sepsis but may have a small benefit in terms of preventing less serious infections.
经会阴前列腺活检与经直肠途径相比,感染并发症的风险显著降低。事实上,经会阴前列腺活检的感染并发症风险非常低,以至于围手术期使用抗生素的效用受到质疑。
进行系统评价和荟萃分析,以评估在经会阴前列腺活检时使用和不使用围手术期抗生素预防的情况下,感染并发症(败血症、非败血症和总体)发生率的差异。
检索了三个电子数据库(PubMed、Embase和MEDLINE),纳入的研究需包括接受经会阴前列腺活检的患者、2000年1月以后发表、包含围手术期抗生素使用信息并报告活检后并发症。采用系统评价和荟萃分析的首选报告项目以及医疗保健研究与质量机构的指南。
共识别出106项描述112组患者的独特研究,其中98项(37805名男性)接受了抗生素预防,14项(4772名男性)未接受。所有患者均纳入败血症并发症分析。接受抗生素治疗的男性组中,共有19/37805(0.05%)例败血症发作,与未使用抗生素组的4/4772(0.08%)例相似(P = 0.2)。对于总体感染(败血症加非败血症),在有可评估数据的接受和未接受抗生素预防的男性中,分别有403/29880(1.35%)和58/4772(1.22%)例事件(P = 0.8)。将分析限制在活检针数较少(<25针)的可比研究中,两组之间败血症发生率仍无差异,但使用抗生素时感染并发症风险有小幅统计学显著降低——67/12140(0.55%)与58/4772(1.22%);P < 0.01。
无论是否使用抗生素预防,经会阴前列腺活检后发生败血症感染的可能性都很低。在此操作中省略围手术期抗生素有望通过避免潜在的药物反应使患者受益。此外,这种做法符合整个医学界改善抗生素管理的呼吁。
在一项大型系统评价和荟萃分析中,我们评估了经会阴前列腺活检时使用或不使用预防性抗生素后的感染并发症。我们得出结论,预防性抗生素不会降低活检后败血症的发生率,但在预防不太严重的感染方面可能有小幅益处。